Chi-Yi Chen

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 447 citations

Hepatology, Viral Hepatitis, Hepatitis B +9

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Chih‐Min Chang et al. · The Lancet Infectious Diseases · 2019 · 199 citations

Probiotic, Dysbiosis, Randomised Trial +9

Arsenic levels in drinking water and mortality of liver cancer in Taiwan

Hung‐Jung Lin, Tzu‐Ching Sung, Chi-Yi Chen et al. · Journal of Hazardous Materials · 2013 · 137 citations

Drinking Water, Hepatology, Health Sciences +14

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

Chun‐Jen Liu, Wan‐Long Chuang, I‐Shyan Sheen et al. · Gastroenterology · 2017 · 118 citations

Hcv Infection, Hepatitis C, Viral Hepatitis +10